Undifferentiated Pleomorphic Sarcoma

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2024-07-17
Clinical Trial Update: Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma [Phase 3]
A Phase 3 trial (Brightline-3) testing brigimadlin in combination with ezabenlimab for advanced soft tissue sarcoma, including undifferentia…